“We know that Alzheimer’s disease develops over decades, but most of the diagnostic tools focus on late-stage pathology when it is too late to intervene,” said Ruogu Fang, Ph.D., a professor of biomedical engineering at the University of Florida who led the new study. “By looking at novel biomarkers, like retinal health, we offer new opportunities to identify patients at risk, offer appropriate tests and encourage them to develop healthy lifestyles to mitigate their risk.”

Fang and her collaborators, including UF’s Adam Woods, Ph.D., and Meta researcher Yunchao Yang, Ph.D., have published their findings in the Journal of Alzheimer’s Disease.